omniture
logo
Search
苏州新芽基因生物技术有限公司
Media Room

Latest News

rss

Suzhou GenAssist Therapeutic Co.,Ltd recently announced that its first base editing product, GEN6050, has submitted a pre-IND application to the FDA and has been accepted

SUZHOU, China, May 6, 2023 /PRNewswire/ -- Suzhou GenAssist Therapeutic Co.,Ltd recently announced ...

2023-05-06 21:00 4622